Danielsen (born 1963) was elected to the Board in 2004 and appointed chairman in 2010. He holds an MBA in Finance and Swiss Business Law from the University of Fribourg in Switzerland, 1987. Since 1993, he has been acting as an independent health care analyst and consultant, advising both young growth companies as well as private and industrial investors on a variety of subjects including company evaluations, equity financing and operational communication strategies. Mr. Danielsen continues to support the activities of Bridge Relations Ltd and Analitika SA, two consulting companies he originally founded. In mid 2012 he assumed the role as CEO of Spring Medical SA, a marketer of next-generation medical device technologies, predominantly in Switzerland and Austria. Mr. Danielsen is a co-founder of Spring Medical, which has its corporate headquarters in Mezzovico, Switzerland. Danielsen previously worked as an equity strategist and analyst for Credit Suisse in Zurich and Credit Suisse First Boston in New York. Danielsen is a member of the following companies: Analitika SA, Spring Medical SA adn Bridge Realtions Ltd. As of December, 2016, he owns 4,500 shares in ContextVision through ORCA Ventures AG, a closely held investment company.  

 Pathology